Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7741391 | 0.89 | CYP3A4 (0.37) | CYP3A4 | |
| SCHEMBL7745730 | 0.80 | DRD2 (0.34) | CYP3A4TSHRPTK2B | |
| SCHEMBL7741398 | 0.78 | CYP3A4 (0.50) | CYP3A4TSHRPTK2BMEN1KMT2A | |
| SCHEMBL7745821 | 0.77 | CYP3A4 (0.48) | CYP3A4TSHRMEN1KMT2A | |
| SCHEMBL8363984 | 0.77 | CYP3A4 (0.39) | CYP3A4TSHRPTK2BMEN1USP2 | |
| SCHEMBL7746706 | 0.75 | CYP3A4 (0.40) | CYP3A4TSHRMEN1KMT2A | |
| SCHEMBL8363985 | 0.74 | CYP3A4 (0.40) | CYP3A4MEN1KMT2A | |
| SCHEMBL7745448 | 0.74 | TSHR (0.35) | TSHRPTK2BMEN1USP2KMT2A | |
| SCHEMBL7741750 | 0.73 | CYP3A4 (0.44) | CYP3A4TSHRPTK2BMEN1USP2 | |
| SCHEMBL7745843 | 0.73 | CYP3A4 (0.38) | CYP3A4TSHRPTK2BMEN1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6774134-B2 | FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | BRISTOL-MYERS SQUIBB COMPANY | 2004-08-10 | — | — | US | disclosed |